Citation Impact

Citing Papers

Resistin, an Adipokine with Potent Proinflammatory Properties
2005
Extracellular HMGB1 as a Proinflammatory Cytokine
2004
Ferroptosis: molecular mechanisms and health implications
2020 Standout
RAGE: A journey from the complications of diabetes to disorders of the nervous system – striking a fine balance between injury and repair
2005
The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis
2010 Standout
Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease
2009
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
2003
HMGB1 in the Immunology of Sepsis (Not Septic Shock) and Arthritis
2004
Necroinflammation in Kidney Disease
2015
HMGB1 is a potent trigger of arthritis
2004
Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes
2007
Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer’s disease
2009
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
2004 Standout
The nuclear protein HMGB1, a new kind of chemokine?
2003
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
2010 Standout
Alarmins: awaiting a clinical response
2012
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury
2008
Interleukin-6 and high mobility group box protein-1 in synovial membranes and osteochondral fragments in equine osteoarthritis
2008
Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children
2016 Standout
HMGB1: guiding immunity from within
2005
Microglial cell origin and phenotypes in health and disease
2011 Standout
Sepsis-induced myocardial dysfunction: pathophysiology and management
2016
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment
2007 Standout
Immunogenic cell death in cancer and infectious disease
2016 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Chromatin and cell death
2003
The molecular machinery of regulated cell death
2019 Standout
Severe Sepsis and Septic Shock
2013 Standout
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism
2005
Resveratrol Reduces the Proinflammatory Effects and Lipopolysaccharide- Induced Expression of HMGB1 and TLR4 in RAW264.7 Cells
2014 Standout
Extracellular role of HMGB1 in inflammation and sepsis
2004
Skeletal infections: microbial pathogenesis, immunity and clinical management
2022 Standout
Intracellular Staphylococcus aureus in bone and joint infections: A mechanism of disease recurrence, inflammation, and bone and cartilage destruction
2020
Monoclonal Anti-HMGB1 (High Mobility Group Box Chromosomal Protein 1) Antibody Protection in Two Experimental Arthritis Models
2011
Sensors of the innate immune system: their link to rheumatic diseases
2010 StandoutNobel
Adipokines in inflammation and metabolic disease
2011 Standout
Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis
2017
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Chronic Implant-Related Bone Infections—Can Immune Modulation be a Therapeutic Strategy?
2019
Soluble form of a receptor for advanced glycation end products sRAGE as a biomarker
2010
Extracellular matrix structure
2015 Standout
IL-6 in Inflammation, Immunity, and Disease
2014 Standout
Obesity in autoimmune diseases: Not a passive bystander
2014
RAGE (receptor for advanced glycation end products): a central player in the inflammatory response
2004
Cellular processing of platinum anticancer drugs
2005 Standout
Neurodegeneration and Inflammation
2008
Targeting HMGB1 in inflammation
2009
Sepsis and septic shock
2018 Standout
HMGB1 in health and disease
2014
Acute kidney injury
2021 Standout
Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation
2005
HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins
2016
Acute respiratory distress syndrome
2019 Standout
Human skin commensals augment Staphylococcus aureus pathogenesis
2018
From endoplasmic-reticulum stress to the inflammatory response
2008 StandoutNature
Sterile inflammation: sensing and reacting to damage
2010 Standout
Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation
2011
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications
2016
High-mobility group box 1 (HMGB1) protein: Friend and foe
2006
The inflammatory response in myocardial injury, repair, and remodelling
2014 Standout
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
2006 Standout
The acute respiratory distress syndrome
2012 Standout
RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
2009
The role of resistin as a regulator of inflammation: Implications for various human pathologies
2009
Association between the RAGE G82S polymorphism and Alzheimer’s disease
2009
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
2007 Standout
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
2006 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
2016 Standout
High Mobility Group Box Protein 1: An Endogenous Signal for Dendritic Cell Maturation and Th1 Polarization
2004
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction
2006 Standout
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective
2017 Standout
Adipokines in Arthritis: New Kids on the Block
2009
Advanced Glycation End Products
2006 Standout
The Broad Scope of Health Effects from Chronic Arsenic Exposure: Update on a Worldwide Public Health Problem
2013 Standout
Glycation, Inflammation, and RAGE
2003
DAMPening Inflammation by Modulating TLR Signalling
2010
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Low molecular weight heparin suppresses receptor for advanced glycation end products‐mediated expression of malignant phenotype in human fibrosarcoma cells
2013
Oxidative Stress and Diabetic Complications
2010 Standout
Pulmonary Biomarkers Based on Alterations in Protein Expression after Exposure to Arsenic
2007
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
2011
HMGB1 and RAGE in Inflammation and Cancer
2010
Is RAGE Still A Therapeutic Target For Alzheimer’s Disease?
2012
Flavonoids as Potential Anti-Inflammatory Molecules: A Review
2022 Standout
Mechanisms of Diabetic Complications
2013 Standout
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)–Induced Pulmonary Hypertension
2015 StandoutNobel
Receptor for Advanced Glycation End Products and Its Involvement in Inflammatory Diseases
2013
RAGE and ICAM-1 cooperate in mediating leukocyte recruitment during acute inflammation in vivo
2010
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
HMGB1: Endogenous Danger Signaling
2008
Mini‐review: The nuclear protein HMGB1 as a proinflammatory mediator
2004
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy
2016
High mobility group box 1 protein as a late-acting mediator of acute lung inflammation.
2004
Neutrophils and arthritis: Role in disease and pharmacological perspectives
2016
DAMPs, PAMPs and alarmins: all we need to know about danger
2006 Standout
Immunogenic Cell Death in Cancer Therapy
2012 Standout

Works of Rille Pullerits being referenced

Induction of arthritis by high mobility group box chromosomal protein 1 is independent of tumour necrosis factor signalling
2008
Pathogenic Transdifferentiation of Th17 Cells Contribute to Perpetuation of Rheumatoid Arthritis during Anti-TNF Treatment
2015
CTLA4 Immunoglobulin but Not Anti–Tumor Necrosis Factor Therapy Promotes Staphylococcal Septic Arthritis in Mice
2015
Extracellular cytochrome c, a mitochondrial apoptosis-related protein, induces arthritis
2004
High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis
2003
IL-1 Receptor Antagonist Treatment Aggravates Staphylococcal Septic Arthritis and Sepsis in Mice
2015
The YIN and YANG of lipoproteins in developing and preventing infectious arthritis by Staphylococcus aureus
2019
The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial
2009
HMGB1 Levels Are Increased in Patients with Juvenile Idiopathic Arthritis, Correlate with Early Onset of Disease, and Are Independent of Disease Duration
2013
Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control
2005
Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via β2 integrin Mac‐1
2006
Intra-peritoneal sRAGE treatment induces alterations in cellular distribution of CD19+, CD3+ and Mac-1+ cells in lymphoid organs and peritoneal cavity
2012
Resistin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis
2008
The Combination of a Tumor Necrosis Factor Inhibitor and Antibiotic Alleviates Staphylococcal Arthritis and Sepsis in Mice
2011
Rankless by CCL
2026